English
Dr Reddy's Laboratories Q3 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,229.25
17.90 (1.48%)
17.90 (1.48%)Volume62.11 K
Updated: Wed 12 Nov, 2025 | 15:40:32
NSE
1,229.6018.10 (1.49%)
18.10 (1.49%)Volume1.22 M
Updated: Wed 12 Nov, 2025 | 15:43:28
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 6,579.60 | 6,358.70 | 3.47% |
| Depreciation/ Amortization | 471.40 | 397.00 | 18.74% |
| Operating Income | 1,801.60 | 1,679.50 | 7.27% |
| Net Income | 1,413.70 | 1,255.70 | 12.58% |
| Net Income Before Taxes | 1,874.30 | 1,917.40 | -2.25% |
| Total Revenue | 8,381.20 | 8,038.20 | 4.27% |
| Selling/ General/ Admin Expenses Total | 3,527.10 | 3,502.60 | 0.70% |
| Diluted Normalized EPS | 16.94 | 15.85 | 6.86% |